86 related articles for article (PubMed ID: 25472539)
1. Prolactin-induced protein in breast cancer.
Naderi A
Adv Exp Med Biol; 2015; 846():189-200. PubMed ID: 25472539
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer.
Naderi A; Meyer M
Breast Cancer Res; 2012 Jul; 14(4):R111. PubMed ID: 22817771
[TBL] [Abstract][Full Text] [Related]
3. Prolactin-Induced Protein regulates cell adhesion in breast cancer.
Vanneste M; Naderi A
Biochem Biophys Res Commun; 2015 Dec; 468(4):850-6. PubMed ID: 26585492
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-induced protein is required for cell cycle progression in breast cancer.
Naderi A; Vanneste M
Neoplasia; 2014 Apr; 16(4):329-42.e1-14. PubMed ID: 24862759
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner.
Baniwal SK; Chimge NO; Jordan VC; Tripathy D; Frenkel B
PLoS One; 2014; 8(6):e62361. PubMed ID: 23755096
[TBL] [Abstract][Full Text] [Related]
6. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D.
Murphy LC; Tsuyuki D; Myal Y; Shiu RP
J Biol Chem; 1987 Nov; 262(31):15236-41. PubMed ID: 3667631
[TBL] [Abstract][Full Text] [Related]
7. Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation.
Baniwal SK; Little GH; Chimge NO; Frenkel B
J Cell Physiol; 2012 May; 227(5):2276-82. PubMed ID: 21809344
[TBL] [Abstract][Full Text] [Related]
8. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
Carsol JL; Gingras S; Simard J
Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
[TBL] [Abstract][Full Text] [Related]
9. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
Gangadharan A; Nyirenda T; Patel K; Jaimes-Delgadillo N; Coletta D; Tanaka T; Walland AC; Jameel Z; Vedantam S; Tang S; Mannion C; Lee GY; Goy A; Pecora A; Suh KS
Breast; 2018 Jun; 39():101-109. PubMed ID: 29656222
[TBL] [Abstract][Full Text] [Related]
10. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator-Novel Insights from Knockout Mice.
Ihedioha OC; Shiu RP; Uzonna JE; Myal Y
DNA Cell Biol; 2016 Oct; 35(10):537-541. PubMed ID: 27602994
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
12. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-inducible proteins in human breast cancer cells.
Shiu RP; Iwasiow BM
J Biol Chem; 1985 Sep; 260(20):11307-13. PubMed ID: 2863272
[TBL] [Abstract][Full Text] [Related]
14. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
15. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
Urbaniak A; Jablonska K; Suchanski J; Partynska A; Szymczak-Kulus K; Matkowski R; Maciejczyk A; Ugorski M; Dziegiel P
Sci Rep; 2023 Apr; 13(1):6574. PubMed ID: 37085653
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
[TBL] [Abstract][Full Text] [Related]
17. mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function.
Li YJ; Liu G; Li Y; Vecchiarelli-Federico LM; Liu JC; Zacksenhaus E; Shan SW; Yang BB; Li Q; Dash R; Fisher PB; Archer MC; Ben-David Y
Mol Cancer Res; 2013 Jun; 11(6):593-603. PubMed ID: 23468528
[TBL] [Abstract][Full Text] [Related]
18. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status.
Murphy LC; Lee-Wing M; Goldenberg GJ; Shiu RP
Cancer Res; 1987 Aug; 47(15):4160-4. PubMed ID: 3607757
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of breast cancer cell lines by a low-density microarray.
de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
